Type of I.P :
Patent A government authority or licence conferring a right or title for a set period, especially the sole right to exclude others from making, using, or selling an invention.
Copyright The exclusive and assignable legal right, given to the originator for a fixed number of years, to print, publish, perform, film, or record literary, artistic, or musical material.
Trademark A symbol, word, or words legally registered or established by use as representing a company or product.
Others Trade Secerts, Innovative Step, Creative etc
Patent Title : A Medicament For Treating Dengue
Patent Registration No : MY142050
R&D The invention is at the lab stage or proof concept stage
Pre-Commercial The invention is currently in the process of field testing
Ready For Market Invention is ready to be licensed out or sold
Selling Method :
Exclusive Licensing No person or company other than the named licensee can exploit the relevant intellectual property rights. Importantly, the licensor is also excluded from exploiting the intellectual property rights.
Licensing Authorization to use a particular patent. Licensee may not be the only one licensed to exploit the intellectual property.
Assignment The sale of ownership to the individual assigning the intellectual property.
Product Year :
This invention intends to provide a medicament which comprises of dengue protease inhibitor for treating dengue. The inhibitor is derived from plants and is in the form of a compound.
- Treating dengue
- Flavivirus ifection
- Treatment of Dengue
The Present Invention Discloses A Plant Derived Compound; Piperine, For Treating Flavivirus Infection, In Particular Dengue Viral Infection. Piperine Can Be Applied As A Non-Peptide Protease Inhibitor Which Specifically Acts On Dengue Virus Serotype 2 Ns2b/3 Protease Complexes. Thus, Piperine Can Be Used As The Dengue Protease Inhibitors For Treatment Of Dengue Viral Infection.
Treatment of Dengue